As drug developers face mounting pressure to accelerate discovery timelines without sacrificing quality, QLNS-CHO offers a compelling solution.

We learn more about the CellCelector, its applications, how it overcomes the limitations of other instruments and top tips ...

LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...

Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle East & North Africa) licensing ...

In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.

Canadian food tech startup Opalia has secured a commercial supply agreement for cell-based dairy, weeks ahead of an expected ...

A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.

It was a busy day in the weather department yesterday. Meteorologist Adam Rutt looks at what set up Monday’s storms. For the ...

The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients ...

This innovative system allows Trailhead to develop specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. TrailBio ® A9 Dopaminergic Neurons represent one of ...